Nascent Biotech Inc (CE) (NBIO)
USOTC
Year End March 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 3.48M | 0 | 0 | 0 | 750k | 1M | 0 | 0 |
Operating Income | 1.43M | -2.22M | -1.37M | -3.45M | -1.4M | -457k | -2.14M | -2.23M |
Pre Tax Income | 1.38M | -2.22M | -1.37M | -4M | -959k | -470k | -2.8M | -2.09M |
Net Income | 1.14M | -2.22M | -1.37M | -4M | -959k | -470k | -2.8M | -2.09M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0.049 | -0.08 | -0.042 | -0.089 | -0.009 | -0.004 | -0.023 | -0.012 |
EBIT | 1.43M | -2.22M | -1.37M | -3.45M | -1.32M | -457k | -2.16M | -2.23M |
EBITDA | 1.43M | -2.22M | -1.37M | -3.45M | -1.4M | -457k | -2.14M | -2.23M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.